Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05098366 · ClinicalTrials.gov registry record · Early Phase 1
Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound
A Early Phase 1 study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
NCT05098366 is a Early Phase 1 study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 42 participants.
The verdict
NCT05098366, a Early Phase 1 study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.
Interventions
- DRUG Normal saline
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-29 |
| Est. Completion | 2023-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05098366
The ClinicalTrials.gov registry entry for NCT05098366 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT05098366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05098366 about?
NCT05098366 is a clinical study titled "Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound". The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.
What is the current status of trial NCT05098366?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2021-05-29. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05098366?
The interventions under investigation include: Normal saline (DRUG), Furosemide (DRUG).
Who is sponsoring clinical trial NCT05098366?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.